Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Low circulating levels of invariant natural killer T (iNKT) cells in patients with obstructive sleep apnoea syndrome and impaired functional response to hypoxia: Implications for cancer co-morbidity

Brian Kent, Gadintshware Gaoatswe, Michelle Corrigan, Walter McNicholas, Andrew Hogan, Donal O'Shea
European Respiratory Journal 2013 42: 3049; DOI:
Brian Kent
1School of Medicine and Medical Science, University College Dublin, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gadintshware Gaoatswe
1School of Medicine and Medical Science, University College Dublin, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle Corrigan
1School of Medicine and Medical Science, University College Dublin, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter McNicholas
1School of Medicine and Medical Science, University College Dublin, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Hogan
1School of Medicine and Medical Science, University College Dublin, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donal O'Shea
1School of Medicine and Medical Science, University College Dublin, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background

Recent epidemiological studies link obstructive sleep apnoea syndrome (OSAS) with increased cancer incidence and mortality. Invariant natural killer T (iNKT) cells are innate immune cells that play a key role in cancer immunity, with low circulating level of iNKT cells predicting worse prognosis in some forms of cancer. The relationship of OSAS severity with iNKT cell levels has not been examined.

Methods

We measured circulating iNKT cells by flow cytometry in 29 otherwise healthy male snorers being assessed by inpatient polysomnography for OSAS, and examined the relationship of OSAS severity and nocturnal hypoxaemia with iNKT levels, along with the impact of subsequent nCPAP. Using iNKT cell lines, we evaluated the effect of exposure to hypoxia for 24 hours on apoptosis and cytotoxicity.

Results

Patients with severe OSAS had markedly less iNKT cells (0.15%) compared to matched patients with moderate (0.22%) or no sleep apnoea (0.38%) (p0.005). The level of iNKT cells correlated inversely with apnoea-hypopnoea index (r=-0.6369; p<0.001) and oxygen desaturation index (r=-0.6846; p<0.005). No such relationship was seen with body mass index or age. Following 6 months nCPAP therapy, iNKT cell frequency increased (p<0.05). Exposure of iNKT cells to hypoxia resulted in increased apoptosis (p<0.05), and impaired cytotoxicity (p<0.05).

Conclusion

Patients with OSAS have significantly reduced levels of circulating iNKT cells, which increase with nCPAP. Furthermore, hypoxia leads to impaired iNKT cell function. These observations may partly contribute to increased cancer risk in OSAS.

  • Sleep disorders
  • Neoplastic diseases
  • Immunology
  • © 2013 ERS
Previous
Back to top
Vol 42 Issue Suppl 57 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Low circulating levels of invariant natural killer T (iNKT) cells in patients with obstructive sleep apnoea syndrome and impaired functional response to hypoxia: Implications for cancer co-morbidity
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Low circulating levels of invariant natural killer T (iNKT) cells in patients with obstructive sleep apnoea syndrome and impaired functional response to hypoxia: Implications for cancer co-morbidity
Brian Kent, Gadintshware Gaoatswe, Michelle Corrigan, Walter McNicholas, Andrew Hogan, Donal O'Shea
European Respiratory Journal Sep 2013, 42 (Suppl 57) 3049;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Low circulating levels of invariant natural killer T (iNKT) cells in patients with obstructive sleep apnoea syndrome and impaired functional response to hypoxia: Implications for cancer co-morbidity
Brian Kent, Gadintshware Gaoatswe, Michelle Corrigan, Walter McNicholas, Andrew Hogan, Donal O'Shea
European Respiratory Journal Sep 2013, 42 (Suppl 57) 3049;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Telemetrically triggered interventions in the first month of cpap treatment - A prospective, randomized controlled intervention trial in patients with a new diagnosis of obstructive sleep apnea syndrome
  • Telehealthcare interventions in the management of obstructive sleep apnoea hypopnoea syndrome (OSAHS) in continuous positive airway pressure (CPAP) users - A systematic review
  • Home telemonitoring and adjustement of CPAP settings in patients with sleep apnea
Show more 4.2 Sleep and Control of Breathing

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society